Insider Trading & Ownership of Mark Chin

Location: London, United Kingdom
Summary: The estimated net worth of Mark Chin is at least $35,696,950 dollars as of 13 Jun 2025. Mark Chin is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $35.48M. Mark Chin is the Former Director of Pyxis Oncology, Inc. and owns shares of Pyxis Oncology, Inc. (PYXS) stock worth about $161.6K. Mark Chin is the Director of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. stock worth about $32.2K. Mark Chin is the Director of Iterum Therapeutics plc and owns shares of Iterum Therapeutics plc (ITRM) stock worth about $25.6K.
Signature: By: /s/ Rahul Khara, as Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Mark Chin files a new Insider Trading report.

Ownership of Mark Chin

Symbol	Company	Relationship	Holdings Value	Report Period
ELVN	IMARA Inc.	Director	$35,477,530	02 Jun 2022
PYXS	Pyxis Oncology, Inc.	Former Director	$161,592	21 Apr 2022
HARP	Harpoon Therapeutics, Inc.	Director	$32,200	08 Mar 2024
ITRM	Iterum Therapeutics plc	Director	$25,628	15 Jun 2023
IRON	Disc Medicine, Inc.	Director		11 Jun 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.